Merit Medical Systems, Inc.
MMSI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -3.05 | 5.41 | 8.26 | -24.82 |
| FCF Yield | 1.04% | 1.90% | 0.31% | 1.14% |
| EV / EBITDA | 67.39 | 71.53 | 86.56 | 83.59 |
| Quality | ||||
| ROIC | 1.27% | 1.49% | 1.43% | 1.39% |
| Gross Margin | 48.52% | 48.24% | 48.41% | 48.71% |
| Cash Conversion Ratio | 2.70 | 2.56 | 1.35 | 2.46 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.40% | 6.14% | 5.78% | 5.63% |
| Free Cash Flow Growth | -50.86% | 450.15% | -70.46% | 72.42% |
| Safety | ||||
| Net Debt / EBITDA | 5.39 | 5.68 | 5.50 | 5.75 |
| Interest Coverage | 6.31 | 6.92 | 6.25 | 4.57 |
| Efficiency | ||||
| Inventory Turnover | 0.61 | 0.61 | 0.58 | 0.60 |
| Cash Conversion Cycle | 173.39 | 168.35 | 179.67 | 170.37 |